Collaboration and a Connection to T1D Researchers: Breakthrough T1D-nPOD Annual Meeting
I’ve just gotten back from the 12th Network for Pancreatic Organ Donors with Diabetes (nPOD) Annual Meeting, which was held February 23-26, 2020, and featured some of the most world-renowned diabetes investigators. nPOD is now the world’s largest tissue bank dedicated to the study of the human pancreas in type 1 diabetes (T1D), and the […]
Breakthrough T1D Receives Legacy Gift from the Estate of Marguerite Rosner
Generous donation furthers Breakthrough T1D mission to treat, prevent and find cures for type 1 diabetes.
Two Long-Time Volunteers Elected to Lead Breakthrough T1D International Board of Directors
The Breakthrough T1D International Board of Directors (IBOD) named two long-time volunteers to serve as Chair and Vice Chair when current board leaders end their two-year terms on July 1. Joseph P. Lacher, Jr., who is President and Chief Executive Officer of Kemper Corporation, will serve as Breakthrough T1D Chair, succeeding current Chair Ellen Leake. […]
ATTD Conference Brings Together Top Minds in Diabetes Research
Each year diabetes researchers from all over the world gather for the annual meeting of the Advanced Technologies & Treatments for Diabetes (ATTD), which this year took place on February 19-22 in Madrid, Spain. Many of the latest advances will be discussed, including research that Breakthrough T1D has funded to advance new breakthroughs and therapies […]
More People Being Diagnosed with Type 1 Diabetes
CDC report shows nearly 30% increase in T1D diagnoses, with most pronounced growth among youth of diverse populations.
Breakthrough T1D Mission Summit Salutes Type 1 Diabetes Research
Ellen Leake, Chair of the International Board of Directors
Breakthrough T1D Awards World-Renowned T1D Researchers
Breakthrough T1D is honored to recognize five leading international researchers whose work has and is transforming type 1 diabetes (T1D) science. We also are proud that our funding has helped drive their work forward toward both curing type 1 diabetes and improving the lives of those living with the disease today. The recipient of the […]
Study: Disease-Modifying Therapies Needed to Offset Costs of Type 1 Diabetes
A new study commissioned by the Breakthrough T1D T1D Fund spotlights the high economic burden of type 1 diabetes (T1D) and the tremendous value of accelerating disease-modifying therapies. The study, released today, estimates the annual cost of T1D is more than $30 billion in the United States, where 1.6 million people are living with the […]
Where Are They Now? Derek and Emily Rapp Seek to Grow Support for Breakthrough T1D
When Derek Rapp stepped down as President and CEO of Breakthrough T1D last year, he vowed he’d never be far away. Holding true to his promise, immediately after relocating back to St. Louis, he and his wife Emily checked in with the local chapter. What could they do? How could they help build the strongest […]
Universal Screening for Type 1 Diabetes: Its Time has Come?
Universal screening for type 1 diabetes (T1D) is a priority for Breakthrough T1D, but the cost versus benefits remain unclear. Now, a large-scale population study in Bavaria, Germany, headed by Breakthrough T1D-funded Anette-Gabriele Ziegler, M.D., Ph.D., has a clue. The Fr1da study of nearly 100,000 children suggests that screening for autoantibodies—antibodies that are directed toward your […]
